Salbutamol/albuterol
Sponsors
Novartis Pharmaceuticals, GlaxoSmithKline, Sanofi
Conditions
AsthmaChronic Obstructive Pulmonary Disease
Phase 1
Phase 2
A 3-period Crossover Study With GSK573719 as Monotherapy in Adult Subjects With Asthma
CompletedNCT01641692
Start: 2012-05-31End: 2013-02-28Updated: 2017-03-09
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
CompletedNCT01854047
Start: 2013-06-30End: 2015-04-30Updated: 2017-06-26
Phase 3
Effect of QVA149 Versus NVA237 and Tiotropium on Chronic Obstructive Pulmonary Disorder (COPD) Exacerbations
CompletedNCT01120691
Start: 2010-04-30End: 2012-07-31Updated: 2013-12-02
The Effect of QVA149 on Patient Reported Dyspnea in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
CompletedNCT01490125
Start: 2011-10-31End: 2012-08-31Updated: 2013-12-24
Efficacy, Safety, and Tolerability of NVA237 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD)
CompletedNCT01613326
Start: 2012-06-30End: 2013-01-31Updated: 2014-04-23
Phase 4
Related Papers
10 more papers not shown